Everest Medicines Limited (1952.HK)

HKD 49.7

(1.84%)

Net Debt Summary of Everest Medicines Limited

Everest Medicines Limited's latest annual net debt in 2023 was -12.43 Million CNY , down -196.21% from previous year.
Everest Medicines Limited's latest quarterly net debt in 2024 Q1 was - CNY , up 100.0% from previous quarter.
Everest Medicines Limited reported annual net debt of 12.92 Million CNY in 2022, up 100.6% from previous year.
Everest Medicines Limited reported annual net debt of -2.15 Billion CNY in 2021, up 46.58% from previous year.
Everest Medicines Limited reported quarterly net debt of -2.47 Million CNY for 2023 Q3, up 99.51% from previous quarter.
Everest Medicines Limited reported quarterly net debt of -12.43 Million CNY for 2023 FY, down -196.21% from previous quarter.

Annual Net Debt Chart of Everest Medicines Limited (2023 - 2018)

Historical Annual Net Debt of Everest Medicines Limited (2023 - 2018)

Year	Net Debt	Net Debt Growth
2023	-12.43 Million CNY	-196.21%
2022	12.92 Million CNY	100.6%
2021	-2.15 Billion CNY	46.58%
2020	-4.03 Billion CNY	-6077.13%
2019	-65.3 Million CNY	60.84%
2018	-166.76 Million CNY	0.0%

Year	Net Debt	Net Debt Growth
2024 Q1	- CNY	100.0%
2023 Q3	-2.47 Million CNY	99.51%
2023 FY	-12.43 Million CNY	-196.21%
2023 Q4	-12.43 Million CNY	-402.51%
2023 Q2	-510.26 Million CNY	-4.47%
2023 Q1	-488.43 Million CNY	-3878.41%
2022 Q4	12.92 Million CNY	-45.05%
2022 Q3	23.52 Million CNY	101.62%
2022 Q2	-1.44 Billion CNY	-0.01%
2022 Q1	-1.44 Billion CNY	32.78%
2022 FY	12.92 Million CNY	100.6%
2021 Q3	-2.15 Billion CNY	39.03%
2021 Q2	-3.53 Billion CNY	-0.02%
2021 Q1	-3.53 Billion CNY	12.3%
2021 FY	-2.15 Billion CNY	46.58%
2021 Q4	-2.15 Billion CNY	0.07%
2020 Q4	-4.03 Billion CNY	0.0%
2020 Q1	-24.22 Million CNY	0.0%
2020 Q3	-4.03 Billion CNY	-5588.23%
2020 Q2	73.46 Million CNY	403.24%
2020 FY	-4.03 Billion CNY	-6077.13%
2019 FY	-65.3 Million CNY	60.84%
2019 Q1	183.89 Million CNY	0.0%
2018 FY	-166.76 Million CNY	0.0%

Peer Net Debt Comparison of Everest Medicines Limited

Name	Net Debt	Net Debt Difference
Uni-Bio Science Group Limited	-76.36 Million HKD	83.715%
CK Life Sciences Int'l., (Holdings) Inc.	5.26 Billion HKD	100.236%